KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Plants, Exosomes and Doggybones

The KTN and the Centre of Excellence in Biopharmaceuticals (COEBP) co-hosted a meeting on 1st October 2015 at Manchester Institute of Biotechnology entitled. This proved to be a great opportunity for networking with industry and academia people from a varied background of medical, industrial and synthetic biology.

Talks at the meeting explored the advantages of different approaches to producing biologics including manufacturing them in plants, in insect viruses and using synthetic approaches.  There was a fascinating talk on the use of exosomes in regenerative medicine, noting that certain effects of regenerative therapy may be delivered by the contents of exosomes produced by the cells. If exosomes become a product in their own right this would throw up unique challenges when it comes to manufacture and characterisation.  In a networking session to scope the challenges of vector design, one of the clear issues to emerge was the need for more tools to provide greater predictability in expression of biologics. This was also the theme for one of the talks given by Ian Fotheringham, MD at Ingenza.  Touchlight Genetics who gave a talk on their proprietary Doggybonetm DNA approach were separately awarded OBN ‘Best Emerging Biotech’ on the same day as our meeting.